| HOME >> MEDICINE >> TECHNOLOGY |
Table 39: GPCRs in Drug Discovery, Major Phase III Molecules for Genito-Urinary System and Sex Hormones Indications, 2011 84
Table 40: GPCRs in Drug Discovery, Top 10 Indications By Total Molecules in Pipeline, 2011 86
Table 41: GPCRs in Drug Discovery, Diabetes, Number of Molecules Targeting GPCRs By Phase, 2011 88
Table 42: GPCRs in Drug Discovery, Parkinson's Disease, Number of Molecules Targeting GPCRs By Phase, 2011 91
Table 43: GPCRs in Drug Discovery, Pain, Number of Molecules Targeting GPCRs By Phase, 2011 94
Table 44: GPCRs in Drug Discovery, Schizophrenia, Number of Molecules Targeting GPCRs By Phase, 2011 97
Table 45: GPCRs in Drug Discovery, Obesity, Number of Molecules Targeting GPCRs By Phase, 2011 100
Table 46: GPCRs in Drug Discovery, Hypertension, Number of Molecules Targeting GPCRs By Phase, 2011 103
Table 47: GPCRs in Drug Discovery, Asthma, Number of Molecules Targeting GPCRs By Phase, 2011 106
Table 48: GPCRs in Drug Discovery, Prostate Cancer, Number of Molecules Targeting GPCRs By Phase, 2011 109
Table 49: GPCRs in Drug Discovery, COPD, Number of Molecules Targeting GPCRs By Phase, 2011 112
Table 50: GPCRs in Drug Discovery, Glaucoma, Number of Molecules Targeting GPCRs By Phase, 2011 115
Table 51: GPCRs in Drug Discovery, Heptares Therapeutics Ltd., GPCR Research Profile, 2011 118
Table 52: GPCRs in Drug Discovery, Receptos Inc., GPCR Research Profile, 2011 118
Table 53: GPCRs in Drug Discovery, 7TM Pharma A/S, GPCR Research Profile, 2011 119
Table 54: GPCRs in Drug Discovery, Trevena Inc., GPCR Research Profile, 2011 120
Table 55: GPCRs in Drug Discovery, Cara Therapeutics Inc., GPCR Research Profile, 2011 120
Table 56: GPCRs in Drug Discovery, Addex Pharmaceuticals, GPCR Research Profile, 2011 121
Table 57
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |